ZhiZhong (Joel) Yao
Principal, Sofinnova Partners - Capital Strategy
Zhizhong (Joel) Yao joined us in 2015 as an analyst focusing on investments in the biopharmaceutical sector.
Prior to joining Sofinnova, Zhizhong carried out post-doctoral research at the French National Institute of Agricultural Research, visualizing the localization and dynamics of cytoskeletal proteins as potential new antibiotic targets.
He holds a Ph.D. in chemical biology and systems biology from Harvard University, where he developed quantitative single-cell methods to determine the mechanism of action of antibiotics as well as drug-drug/gene-drug/gene-gene interactions.
He also holds a B.S. in chemistry and molecular engineering from Peking University. Zhizhong was a teaching fellow and life-science residential advisor at Harvard College. His original research and review articles have appeared in peer-reviewed journals such as PNAS, Molecular Cell, PLoS Genetics and Annual Review of Microbiology.
Sectors
Medical Devices & Biopharmaceuticals
